Roche targets continued growth after strong 2024 sales
Roche has reported a 7% increase in full-year 2024 sales at constant exchange rates (CER), reaching CHF 60.5bn ($66.9bn). The …
Post
-
-
All change in Germany – confidential pricing in, IRP out
On 1 January 2025, important legal amendments relating to drug pricing in Germany that were included in the Medical Research …
-
Sanofi reports Q4 2024 increase in net income to $916m
Sanofi has announced an increase in net income from continuing operations for the fourth quarter (Q4) of 2024, reaching €880m …
-
Top 20 biopharma companies’ market caps rise 1.7% over 2024 amid policy
The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by US Federal Reserve interest …
-
NHS England to offer Casgevy for sickle cell disease patients
The CRISPR-based gene therapy Casgevy (exagamglogene autotemcel) has been made available to patients with sickle cell disease in England, following …
-
Hiroyuki Okuzawa succeeds Sunao Manabe as Daiichi Sankyo CEO
Daiichi Sankyo has announced that Hiroyuki Okuzawa will succeed Sunao Manabe as its CEO from 1 April 2025. The company's board …
-
FDA approves Vertex’s acute pain treatment Journavx
The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with acute pain. The …
-
RFK Jr. thrusts domestic manufacturing agenda on Day 2 of confirmation hearings
Robert F. Kennedy Jr. (RFK Jr) has claimed that “China will be able to ransom medical health” in America due …
-
MHRA launches refreshed ILAP to speed up NHS drug access
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has launched a refreshed Innovative Licensing and Access Pathway (ILAP) to …
-
Takeda announces appointment of Julie Kim as CEO
Takeda has announced the appointment of Julie Kim as successor to Christophe Weber, its current president, CEO and representative director, …
-
WHO’s Neglected Tropical Disease Day at unfamiliar odds with US stance
The World Health Organization (WHO) has called for country commitment to combat neglected tropical diseases, as the agency braces itself …
-
Leveragen and Moonlight Bio unite for T-cell therapy development
Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for challenging cancers. The partnership integrates …
-
Acellera and Psivant partner for AI-driven drug discovery
Acellera Therapeutics and Psivant Therapeutics have announced a strategic research partnership aimed at developing computational drug discovery approaches with the …
-
Lyndra Therapeutics appoints Adam Sayer new CEO and president
Lyndra Therapeutics has announced the immediate appointment of Adam Sayer as its new president and CEO. Sayer, who will also join …
-
FDA expands Enhertu approval to include HER2-ultralow breast cancer patients
AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval from the US Food and Drug Administration …
